Your browser doesn't support javascript.
loading
Discovery of rare variants associated with blood pressure regulation through meta-analysis of 1.3 million individuals.
Surendran, Praveen; Feofanova, Elena V; Lahrouchi, Najim; Ntalla, Ioanna; Karthikeyan, Savita; Cook, James; Chen, Lingyan; Mifsud, Borbala; Yao, Chen; Kraja, Aldi T; Cartwright, James H; Hellwege, Jacklyn N; Giri, Ayush; Tragante, Vinicius; Thorleifsson, Gudmar; Liu, Dajiang J; Prins, Bram P; Stewart, Isobel D; Cabrera, Claudia P; Eales, James M; Akbarov, Artur; Auer, Paul L; Bielak, Lawrence F; Bis, Joshua C; Braithwaite, Vickie S; Brody, Jennifer A; Daw, E Warwick; Warren, Helen R; Drenos, Fotios; Nielsen, Sune Fallgaard; Faul, Jessica D; Fauman, Eric B; Fava, Cristiano; Ferreira, Teresa; Foley, Christopher N; Franceschini, Nora; Gao, He; Giannakopoulou, Olga; Giulianini, Franco; Gudbjartsson, Daniel F; Guo, Xiuqing; Harris, Sarah E; Havulinna, Aki S; Helgadottir, Anna; Huffman, Jennifer E; Hwang, Shih-Jen; Kanoni, Stavroula; Kontto, Jukka; Larson, Martin G; Li-Gao, Ruifang.
Affiliation
  • Surendran P; British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Feofanova EV; British Heart Foundation Centre of Research Excellence, University of Cambridge, Cambridge, UK.
  • Lahrouchi N; Health Data Research UK Cambridge, Wellcome Genome Campus and University of Cambridge, Cambridge, UK.
  • Ntalla I; Rutherford Fund Fellow, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Karthikeyan S; Human Genetics Center, Department of Epidemiology, Human Genetics and Environmental Sciences, School of Public Health, University of Texas Health Science Center at Houston, Houston, TX, USA.
  • Cook J; Program in Medical and Population Genetics, Broad Institute of Harvard and MIT, Cambridge, MA, USA.
  • Chen L; Cardiovascular Research Center, Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA.
  • Mifsud B; Amsterdam UMC, University of Amsterdam, Heart Center, Department of Clinical and Experimental Cardiology, Amsterdam Cardiovascular Sciences Amsterdam, Amsterdam, the Netherlands.
  • Yao C; William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
  • Kraja AT; British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Cartwright JH; Department of Biostatistics, University of Liverpool, Liverpool, UK.
  • Hellwege JN; British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Giri A; William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
  • Tragante V; College of Health and Life Sciences, Hamad Bin Khalifa University, Doha, Qatar.
  • Thorleifsson G; Framingham Heart Study, Framingham, MA, USA.
  • Liu DJ; Population Sciences Branch, Division of Intramural Research, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA.
  • Prins BP; Division of Statistical Genomics, Department of Genetics and Center for Genome Sciences and Systems Biology, Washington University School of Medicine, St Louis, MO, USA.
  • Stewart ID; William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
  • Cabrera CP; Division of Epidemiology, Department of Medicine, Institute for Medicine and Public Health, Vanderbilt Genetics Institute, Vanderbilt University Medical Center, Tennessee Valley Healthcare System (626)/Vanderbilt University, Nashville, TN, USA.
  • Eales JM; Division of Epidemiology, Department of Medicine, Institute for Medicine and Public Health, Vanderbilt Genetics Institute, Vanderbilt University Medical Center, Tennessee Valley Healthcare System (626)/Vanderbilt University, Nashville, TN, USA.
  • Akbarov A; Division of Quantitative Sciences, Department of Obstetrics & Gynecology, Vanderbilt Genetics Institute, Vanderbilt University Medical Center, Tennessee Valley Healthcare System (626)/Vanderbilt University, Nashville, TN, USA.
  • Auer PL; Department of Cardiology, Division Heart & Lungs, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
  • Bielak LF; deCODE genetics/Amgen, Inc, Reykjavik, Iceland.
  • Bis JC; deCODE genetics/Amgen, Inc, Reykjavik, Iceland.
  • Braithwaite VS; Institute of Personalized Medicine, Penn State College of Medicine, Hershey, PA, USA.
  • Brody JA; British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Daw EW; MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Cambridge, UK.
  • Warren HR; William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
  • Drenos F; National Institute for Health Research Barts Cardiovascular Biomedical Research Centre, Queen Mary University of London, London, UK.
  • Nielsen SF; Division of Cardiovascular Sciences, Faculty of Medicine, Biology and Health, University of Manchester, Manchester, UK.
  • Faul JD; Division of Cardiovascular Sciences, Faculty of Medicine, Biology and Health, University of Manchester, Manchester, UK.
  • Fauman EB; Joseph J Zilber School of Public Health, University of Wisconsin, Milwaukee, WI, USA.
  • Fava C; Department of Epidemiology, University of Michigan, Ann Arbor, MI, USA.
  • Ferreira T; Cardiovascular Health Research Unit, Department of Medicine, University of Washington, Seattle, WA, USA.
  • Foley CN; MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Cambridge, UK.
  • Franceschini N; MRC Nutrition and Bone Health Group, University of Cambridge, Cambridge, UK.
  • Gao H; MRC Unit The Gambia at London School of Hygiene & Tropical Medicine, Banjul, Gambia.
  • Giannakopoulou O; Cardiovascular Health Research Unit, Department of Medicine, University of Washington, Seattle, WA, USA.
  • Giulianini F; Division of Statistical Genomics, Department of Genetics and Center for Genome Sciences and Systems Biology, Washington University School of Medicine, St Louis, MO, USA.
  • Gudbjartsson DF; William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
  • Guo X; National Institute for Health Research Barts Cardiovascular Biomedical Research Centre, Queen Mary University of London, London, UK.
  • Harris SE; Department of Life Sciences, College of Health and Life Sciences, Brunel University London, London, UK.
  • Havulinna AS; Institute of Cardiovascular Science, Faculty of Population Health Sciences, University College London, London, UK.
  • Helgadottir A; Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark.
  • Huffman JE; Survey Research Center, Institute for Social Research, University of Michigan, Ann Arbor, MI, USA.
  • Hwang SJ; Internal Medicine Research Unit, Pfizer, Cambridge, MA, USA.
  • Kanoni S; Department of Medicine, University of Verona, Verona, Italy.
  • Kontto J; Department of Clinical Sciences Malmö, Lund University, Malmö, Sweden.
  • Larson MG; The Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, University of Oxford, Oxford, UK.
  • Li-Gao R; British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Nat Genet ; 52(12): 1314-1332, 2020 12.
Article de En | MEDLINE | ID: mdl-33230300
ABSTRACT
Genetic studies of blood pressure (BP) to date have mainly analyzed common variants (minor allele frequency > 0.05). In a meta-analysis of up to ~1.3 million participants, we discovered 106 new BP-associated genomic regions and 87 rare (minor allele frequency ≤ 0.01) variant BP associations (P < 5 × 10-8), of which 32 were in new BP-associated loci and 55 were independent BP-associated single-nucleotide variants within known BP-associated regions. Average effects of rare variants (44% coding) were ~8 times larger than common variant effects and indicate potential candidate causal genes at new and known loci (for example, GATA5 and PLCB3). BP-associated variants (including rare and common) were enriched in regions of active chromatin in fetal tissues, potentially linking fetal development with BP regulation in later life. Multivariable Mendelian randomization suggested possible inverse effects of elevated systolic and diastolic BP on large artery stroke. Our study demonstrates the utility of rare-variant analyses for identifying candidate genes and the results highlight potential therapeutic targets.
Sujet(s)

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Pression sanguine / Prédisposition génétique à une maladie / Fréquence d&apos;allèle / Hypertension artérielle Type d'étude: Clinical_trials / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limites: Humans Langue: En Journal: Nat Genet Sujet du journal: GENETICA MEDICA Année: 2020 Type de document: Article Pays d'affiliation: Royaume-Uni

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Pression sanguine / Prédisposition génétique à une maladie / Fréquence d&apos;allèle / Hypertension artérielle Type d'étude: Clinical_trials / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limites: Humans Langue: En Journal: Nat Genet Sujet du journal: GENETICA MEDICA Année: 2020 Type de document: Article Pays d'affiliation: Royaume-Uni
...